Gravitas Medical
Focus: Gravitas Medical is a 2023-founded San Francisco biotech specializing in feeding tube monitoring devices and generic pharmaceuticals. The company operates in a niche medtech-pharma hybrid model with minimal scale and no disclosed employee count.
Profile data last refreshed 44m ago · AI intelligence enriched 2d ago
Open Jobs
0
About Gravitas Medical
AI assessmentNot HiringNo open roles listed right now. Follow Gravitas Medical to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Gravitas Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$1K Part DDeclining
Post-LOE
Dominant revenue driver (70%) but mature generic competing on price; minimal differentiation and declining trajectory post-LOE.
Help build intelligence for Gravitas Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.